| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance. | Eur J Haematol Suppl | 2008 | 1.04 |
| 2 | Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A. | Hum Mutat | 2007 | 0.96 |
| 3 | Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A. | Hum Mutat | 2005 | 0.93 |
| 4 | Prevalence of small rearrangements in the factor VIII gene F8C among patients with severe hemophilia A. | Hum Mutat | 2002 | 0.84 |
| 5 | Need for Prophylactic Treatment in Adult Haemophilia A Patients. | Transfus Med Hemother | 2009 | 0.77 |
| 6 | Seven novel and four recurrent point mutations in the factor VIII (F8C) gene. | Hum Mutat | 2002 | 0.75 |